Search
news › patent-issued-for-osteoarthritis-gene-therapy
… A potentially disease-modifying therapy for osteoarthritis (OA) has reached a key milestone now that … are affected by OA, a degenerative joint disease, and that number is expected to rise. While currently available … for FX201 is a great step for Flexion, and they are now completing GLP toxicology studies and moving toward clinical …
research › ... › routine-histology-services
… and biochemical relationships between constituent proteins for subsequent analysis (e.g. H&E, immunohistochemistry, … for paraffin processing is typically performed using commercial grade 10 percent Neutral Buffered Formalin. … … staining. … Currently the laboratory offers a limited number of special histochemical stains. These include: …
support › audio-video-conference › services-provided
… consultation services, and production assistance for meetings, events, exhibits, and room installations. With … on a … first-come, first-served basis … . A charge source number for tracking purposes is required; however, only … table $30 $15 Computer - Laptop (PC or Mac) $150 $75 Microphone - Regular $30 $15 Microphone - Wireless Handheld $50 …
research › faculty-labs › perumal-thiagarajan-lab
… The immunological specificity of these antibodies is complex and it ranges from phospholipid binding proteins, a … and anionic phospholipid to anionic phospholipid alone. A number of phospholipid binding protein such as b 2 … identified as an integral component of the complex epitope for these antibodies. The clinical significance of these …
research › ... › the-problem
… mechanisms of change, what we call the mutagenic tetrasect, come together to facilitate the ability of bacteria to … modifications! … It takes around 10 years and $1 billion for a company to bring a new antibiotic to market. Bacteria … Unsurprisingly, as bacterial resistance has increased, the number of companies developing new antibiotics has …
departments › ... › benefits
… See stipends and benefit information on the Baylor College of Medicine’s graduate … to professional success. Our residents have access to a number of programs to support their well-being. View … to help you maintain wellness throughout your training. Information about vacation and leave of absences is available …
news › trial-results-show-potential-benefits-of-tocilizumab-for-covid-19
… clinical trials around the world as a potential treatment for COVID-19. A team of international researchers present … clinical status, the study’s primary endpoint, reducing the number of hospital days is important for patients and for … patients will benefit the most from this treatment. In the coming weeks, results are expected from the REMDACTA trial, …
research › atc-core-labs › antibody-based-proteomics-core
… Core provides cutting edge antibody-based proteomic platforms for both validation and protein biomarker discovery, … samples, laser capture micro-dissected (LCM) samples, small numbers of isolated stem cells or other rare cell types, and … we have developed is to analyze isolated protein complexes. We have developed an epigenetic RPPA platform to …
research › ... › projects
… burden of disease. Oral vaccines are an attractive strategy for immunizing populations, particularly in low-income settings with the highest disease burden; however, the … better vaccine or therapeutics? … Breast milk contains a number of biologically active components such as …
news › botswana-graduates-first-ph-d-scientist-in-collaboration-with-baylor-college-of-medicine
… African populations. Started in 2014, CAfGEN has accomplished most of its aims in the first phase of funding … has built genomic sequencing systems and provided support for the bioinformatic centers in Botswana and Uganda. CAfGEN … and the National Human Genome Research Institute, grant number U54AI110398. … … Botswana graduates first Ph.D. …
